LBS-neurons: Began Phase IIb trial

Layton BioScience Inc., Sunnyvale, Calif. Product: LBS-neurons Business: Neurological, Gene/Cell therapy Therapeutic category: Cell replacement Target: Basal ganglia region of the brain Description: H...